2024 - Go-To-Market Success: The Role of Capital Preservation in Life Science Research and Diagnostic Consumable Manufacturing

In this webinar, Patrick Tuohy will address a critical question encountered by most life science and diagnostic companies: Should the development and/or manufacturing of products be outsourced or in-sourced? The webinar delves into how diagnostic and life science companies can save capital and reduce time to market by outsourcing their development and manufacturing needs.
The speakers will explore the benefits of leveraging pilot line capabilities for life science and diagnostic companies seeking to commercialize their novel innovations. The pilot line capability at SCHOTT MINIFAB consists of a purpose-built infrastructure, backed by decades of manufacturing know-how.
This enables the transformation of clients’ products from initial assembled units (for feasibility testing) to the first commercial articles that contribute to improving patient health and well-being. The speakers will also discuss other outsourcing benefits, along with some drawbacks and strategies to mitigate them.
Register for this webinar to discover strategies for companies to save capital and reduce time to market by outsourcing development and manufacturing needs for product development.
Keywords: Microfluidic, IVD, Diagnostics, Laboratory Technology, Commercial Manufacturing, In Vitro Diagnostics, Microfluidics, Microfluidics-Based System, CDMO/CMO, Commercialization/HEOR/Market Access